OpenAIs AI model for longevity science
OpenAI has created an AI model for longevity science that focuses on engineering proteins to turn regular cells into stem cells. The company claims that its model, GPT-4b micro, has suggested ways to ...
Sam Altman invests $180 million to add 10 years onto human life expectancy through Retro Biosciences
Retro Biosciences, a startup with a goal of adding 10 years onto the average human life span, has received $180 million from Sam Altman, CEO of OpenAI. Altman, a prominent figure in Silicon Valley and...